Nasopharyngeal Diseases  >>  capecitabine  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
capecitabine / Generic mfg.
NCT00439426: A Study of Xeloda (Capecitabine) in Combination With XELOX (Oxaliplatin) in Patients With Metastatic Nasopharyngeal Cancer.

Completed
2
25
RoW
Oxaliplatin, capecitabine [Xeloda]
Hoffmann-La Roche
Nasopharyngeal Cancer
09/09
09/09

Download Options